This book presents original research results on the leading edge of cancer. Topics discussed include coping mechanisms in patients with head and neck cancer; hepatocellular carcinoma; chronic lymphocytic leukaemia; the pathobiology of B-lymphoproliferative disorders from MBL to CLL to SLL; molecular and cellular characterisation of chronic lymphocytic leukemia; pain as a consequence in patients with early stage breast cancer treated with intracavity brachytherapy accelerated partial breast irradiation (IBAPBI); the future of anti-tumour immunotherapy; coping with childhood cancer; and the current clinical utility of Everolimus in the treatment of renal cell carcinoma.